Epoprostenol



Indications and Reactions:

Role Indications Reactions
Primary
Pulmonary Arterial Hypertension 37.5%
Pulmonary Hypertension 37.5%
Crest Syndrome 6.3%
Drug Use For Unknown Indication 6.3%
Oxygen Saturation Decreased 6.3%
Portopulmonary Hypertension 6.3%
Rectal Haemorrhage 12.5%
Thyroxine Increased 12.5%
Vomiting 12.5%
Atrial Fibrillation 6.3%
Fall 6.3%
Helicobacter Infection 6.3%
Hypokalaemia 6.3%
Pulmonary Oedema 6.3%
Throat Tightness 6.3%
Transient Ischaemic Attack 6.3%
Treatment Failure 6.3%
Vulvovaginal Mycotic Infection 6.3%
Weight Decreased 6.3%
Secondary
Pulmonary Arterial Hypertension 35.6%
Drug Use For Unknown Indication 20.0%
Pulmonary Hypertension 16.3%
Nonketotic Hyperglycinaemia 14.8%
Product Used For Unknown Indication 5.9%
Anticoagulant Therapy 1.5%
Pain 1.5%
Drug Abuse 0.7%
Jugular Vein Thrombosis 0.7%
Nausea 0.7%
Prophylaxis 0.7%
Prophylaxis Against Diarrhoea 0.7%
Prophylaxis Of Nausea And Vomiting 0.7%
Pulmonary Oedema 14.0%
Thrombocytopenia 9.3%
Dyspnoea 7.0%
Rash 7.0%
Weight Decreased 7.0%
Device Related Infection 4.7%
Headache 4.7%
Oedema 4.7%
Right Ventricular Failure 4.7%
Sepsis 4.7%
Stress 4.7%
Throat Tightness 4.7%
Unevaluable Event 4.7%
Ventricular Hypertrophy 4.7%
Left Ventricular Failure 2.3%
Multi-organ Failure 2.3%
Palpitations 2.3%
Platelet Count Decreased 2.3%
Premature Baby 2.3%
Pulmonary Arterial Pressure Increased 2.3%
Concomitant
Pulmonary Arterial Hypertension 23.2%
Pulmonary Hypertension 22.7%
Product Used For Unknown Indication 15.1%
Dermatitis Atopic 5.5%
Right Ventricular Failure 3.9%
Atrial Fibrillation 3.7%
Cardiac Failure 2.8%
Rash 2.8%
Analgesic Therapy 2.4%
Cardiac Disorder 2.2%
Anaemia 1.8%
Drug Use For Unknown Indication 1.8%
Hypovolaemia 1.8%
Pneumonia 1.8%
Diabetes Mellitus 1.7%
Non-small Cell Lung Cancer Stage Iiia 1.7%
Anticoagulant Therapy 1.3%
Cor Pulmonale Chronic 1.3%
Prophylaxis Against Gastrointestinal Ulcer 1.3%
Sedation 1.1%
Platelet Count Decreased 16.1%
Pulmonary Arterial Hypertension 7.5%
Right Ventricular Failure 7.5%
Pulmonary Hypertension 6.5%
Swelling 6.5%
Syncope 6.5%
Thrombocytopenia 6.5%
Vomiting 6.5%
Infection 4.3%
Pyrexia 4.3%
Cardiac Failure 3.2%
Device Related Infection 3.2%
General Physical Health Deterioration 3.2%
Myocardial Infarction 3.2%
Pulmonary Oedema 3.2%
Renal Failure 3.2%
Amnesia 2.2%
Chest Pain 2.2%
Condition Aggravated 2.2%
Death 2.2%